DNAH8 and leukemia: Thus, Kim et al. [26] have performed a structure–activity relationship study and synthesized compound 9, which showed potent inhibition of Eg5 ATPase (IC50 of ATPase activity ~60 nM) and in vivo efficacy in the P388 murine leukemia model.